Oncoinvent ASA (7BG)
XDUS
6.98
-0.28 (-3.86%)
Closed
Oct 7, 2026
Day's Range
6.987.26
52 wk Range
1.7913.00
Financial Statements - 7BG - Oncoinvent ASA
Revenue
23.03M▲ 744.2%
Net Income
-155.07M▼ 10.6%Net Margin -673.1%
EBITDA
-122.16M▲ 2.7%
Free Cash Flow
-129.99M▼ 44.8%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Sales | 23.03M | 2.72M | 354K |
| Cost of Goods | - | - | - |
| Gross Profit | - | - | - |
 Operating Expense | - | - | - |
| Operating Income | -136.69M | -142.21M | -191.81M |
| Non-Operating Interest | - | - | - |
| Other Income Expense | - | - | - |
| Pre Tax Income | -155.07M | -140.20M | -190.40M |
| Income Tax | 0 | 0 | 0 |
| Net Income | -155.07M | -140.20M | -190.40M |
| EPS Basic | -125 | -561 | -833.08378 |
| EPS Diluted | -125 | -561 | -833.08378 |
| Basic Shares Outstanding | 1.23M | 249.89K | 223.34K |
| Diluted Shares Outstanding | 1.23M | 249.89K | 223.34K |
| Ebit | -155.04M | -140.12M | -189.82M |
| Ebitda | -122.16M | -125.56M | -189.60M |
| Net Income Continuous Operations | -155.07M | -140.20M | -190.40M |
| Minority Interests | - | - | - |
| Preferred Stock Dividends | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
